Please login to the form below

Not currently logged in
Email:
Password:

People, September, 2011

Recent high-profile moves in the pharmaceutical and healthcare industries
Mover of the month is Dr Christopher Thomson who has appointed as executive director of Astellas Pharma Europe's new European oncology unit

Mover of the month

  
 Christopher Thomson

Astellas Pharma Europe has appointed Dr Christopher Thomson as executive director of its new European oncology unit. He takes up the newly created position after three years as director of business development. Dr Thomson joined Astellas in 2008 from IMS Health where he was group marketing director for medical and patient information, Europe Middle East and Africa. He started his career in the pharmaceutical industry as a sales representative with Schwarz Pharmaceuticals before moving on to hold senior positions within Bayer. 


 

IDEA Pharma has added project managers Suzanne Axford-Bryars and Lidia Markovic to its team. Axford-Bryars has 10 years of consultancy experience. Having previously worked for IDEA, she left to experience working in Italy for a medical education and healthcare advertising firm. Markovic joined IDEA from Movianto UK, part of the Celesio Group, where she acted as key account manager.

 

Suzanne_Lidia



Meelis Reidla  

Meelis Reidla, Bayer's country division head for consumer care, has been elected as the new president of PAGB, the UK trade association for manufacturers of over-the-counter medicines and food supplements. 

RBW Consulting has appointed Katherine Biglen as a researcher in its healthcare communications division.



 Katherine Biglen



TBrett_charlotte

Spectrum Regulatory Solutions, part of the Zaicom International group of companies, has appointed Trevor Brett as commercial director to lead the strategic and tactical direction of business unit relationships and market opportunity development. Spectrum has also appointed Charlotte Cunningham as a project co-ordinator. 


Branding agency 1HQ has added Burton Paul as a client director to head its health division. Paul has more than 15 years of experience in managing projects and clients across a wide range of sectors. His work includes brand delivery for companies including BMS, Cephalon, GE Healthcare, King Pharmaceuticals, Mylan, Peptech and SSL (Reckitt Benckiser). 


Burton Paul

 

 


Dr Bharatt Chowrira

Addex Pharmaceuticals has selected Dr Bharatt Chowrira as its new chief executive. Dr Chowrira joined Addex after serving at Nektar Therapeutics. He has also worked for Merck & Co. and Sirna Therapeutics. 

The MSI Consultancy has appointed Russell Powter as a senior consultant. Powter has more than 20 years' experience in the pharmaceutical industry, gained in his native Australia, in the UK and in Europe. He held a variety of senior sales, marketing and training roles with Merck Sharp & Dohme, and subsequently with Pfizer.

Russell Powter

Delphine Duchateau

Delphine Duchateau has become group director, Phoenix Marketing International, at its offices in Richmond, in the UK. Duchateau has 18 years'  experience in the pharmaceutical sector, having started her career as a sales representative in France and then moving to the UK. She previously worked at TNS Healthcare (now Kantar Health) for eight years, rising to divisional director in the specialist qualitative unit, and more recently spent five years at Hall and Partners as a partner in the health division.

Rock medical communications has added four new people to its specialist medical education team. Sam Flynn has joined as account manager, while Ash Rishi has become account director.Both previously worked at Ogilvy Healthworld Medical Education. Sammy Harfield has been appointed as a senior medical writer. Harfield has six years of agency experience, having previously worked for Ogilvy 4D and Caudex. Lauren Donley has also joined the company as an account executive from Adis International in New Zealand where she was a medical writer.

Rock medical communications

 

Delenex Therapeutics has appointed Dr Thomas Jung as chief medical officer. Previously, Jung led research work in immunology at the Novartis Research Institute in Vienna, Austria, then spent nine years at Novartis in Basel. He was part of the senior leadership team at the Novartis Institute for Biomedical Research (NIBR), most recently as EU head of translational medicine.

Asterand has announced that John Stchur has decided to step down as chief financial officer, with immediate effect. Stchur has been responsible for leading the company financially throughout its growth cycle, most recently negotiating the successful acquisition of BioSeek. Asterand has retained Alan Fishman as the interim CFO.

Ipsen has added executive vice-president, general counsel Nathalie Joannes and executive vice-president, chief financial officer Susheel Surpal to its executive committee. Joannes, a Belgian national, has previously held roles at Genzyme, Monsanto Company and Serono International. Meanwhile Susheel Surpal, a British national, has previously worked for LABCO, Sodexo, the BIC group and the BEL group.

Ketchum has completed its management transition in Germany. Timo Sieg, managing director in Germany and chief executive of Europe, will leave the firm at the end of 2011. Dirk Popp will continue in his role as chief executive of Germany. David Gallagher assumes the position of CEO of Ketchum Pleon, the firm's European operation, with immediate effect.

Patient Intelligence Panel (PIP) has appointed Herman Rutgers and Ben Tegelaars as directors. Rutgers, the company's new chairman, has 30 years' experience of the health, wellness and pharmaceutical industries.
Meanwhile Tegelaars has joined the firm as business development director. Richard Thornton will also support the board in an advisory capacity as a veteran of the online market research industry.


Related links

FAQ: How do I get my move listed

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics